申请人:Berdini Valerio
公开号:US20080167309A1
公开(公告)日:2008-07-10
The invention provides a compound for use in the prophylaxis or treatment of a disease state or condition mediated by a cyclin dependent kinase, the compound having the formula (I):
and salts, tautomers, N-oxides or solvates thereof,
wherein
A is a bond, C═O, NR
g
(C═O) or O(C═O) wherein R
g
is hydrogen or C
1-4
hydrocarbyl optionally substituted by hydroxy or C
1-4
alkoxy;
Y is a bond or an alkylene chain of 1, 2 or 3 carbon atoms in length;
Q is S or CR
2
;
J is S or CH; provided that one of Q and J is S, and the other of Q and J is not S;
when Q is S, there is a double bond between the ring carbon atoms “a” and “b” and a double bond between the ring nitrogen N and J; and when J is S, there is a double bond between Q and the ring carbon atom “a” and a double bond between the ring nitrogen N and the ring carbon atom “b”;
and R
1
to R
4
are as defined in the claims.
本发明提供了一种化合物,用于预防或治疗由细胞周期依赖性激酶介导的疾病状态或病症,该化合物具有以下式子(I)和其盐、互变异构体、N-氧化物或溶剂化物:其中,A是键合、C═O、NRg(C═O)或O(C═O),其中Rg为氢或C1-4烃基,可选地被羟基或C1-4烷氧基取代;Y是长度为1、2或3个碳原子的烷基链或键合;Q是S或CR2;J是S或CH;前提是Q和J中的一个是S,而另一个不是S;当Q是S时,环上碳原子“a”和“b”之间有双键,环氮原子N和J之间也有双键;当J是S时,Q和环上碳原子“a”之间有双键,环氮原子N和环上碳原子“b”之间也有双键;R1至R4如权利要求所定义。